ACannabis 2024 and ACannabis 2024 Industry Dinner

ACannabis 2024
Tuesday 12th March and Wednesday 13th March 2024

Crown Promenade

followed by:

ACannabis 2024 Industry Dinner
Wednesday 13th March 2024

Aviary Crown

with:

MCIA Advisory & Compliance Day
Thursday 14th March 2024

Crown Promenade

MCIA is excited to announce the dates of ACannabis 2024 as 12th and 13th March 2024 at Crown Promenade, Melbourne. 

Continue reading “ACannabis 2024 and ACannabis 2024 Industry Dinner”

Announcing MCIA Advisory & Compliance Day 

Thursday 14th March 2024
Crown Promenade
9am – 5pm

In the medicinal cannabis industry, how do you know what you don’t know? Do you have unanswered questions about compliance and regulatory obligations? Then this practical Advisory & Compliance Day is for you – a chance to connect with experts within the industry.   

Continue reading “Announcing MCIA Advisory & Compliance Day “

MCIA Workshop: Tips for successfully engaging with Human Research Ethics Committee

On 28 October 2022 held a workshop on “Tips for successfully engaging with Human Research Ethics Committee”. This workshop was designed to provide a forum for participants from across the medicinal cannabis industry, and particularly medicinal cannabis companies and research organisations, to discuss approaches to successfully engaging with HREC in the area of clinical trials involving unregistered medicinal cannabis therapeutic goods.

Continue reading “MCIA Workshop: Tips for successfully engaging with Human Research Ethics Committee”

MCIA Virtual Workshop: Tips for successfully engaging with Human Research Ethics Committee

This workshop is designed to provide a forum for participants from across the medicinal cannabis industry, and particularly medicinal cannabis companies and research organisations, to discuss approaches to successfully engaging with HREC in the area of clinical trials involving unregistered medicinal cannabis therapeutic goods.

MCIA is supporting this to assist in enabling and encouraging robust clinical research in the sector.

Date:        28 October 2022
Time:       11:00am – 1.00pm (AEST)
Virtual:    Zoom link will be provided when you register

The workshop will cover:

  • Sponsor obligations and responsibilities
  • Botanical drug product and quality control
  • Preclinical evidence
  • Trial design

Facilitator:

  • Dr Melinda Thompson, Head of Regulatory Affairs & Quality Systems Source Certain and Chair of MCIA Research Working Group

Presenters include:

  • Professor Andrew McLachlan, Head of School & Dean of Pharmacy, University of Sydney
  • Biljana Georgievska, EVP Commercial, Nucleus Network
  • Dr Anastasia Suraev, The Lambert Initiative

Please register below if you would like to attend and you will receive a confirmation email containing information about joining the meeting.